A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements.
Adolescent
Adult
Bone Neoplasms
/ genetics
Child
Child, Preschool
Female
Gene Fusion
Gene Rearrangement
Humans
Infant
Lung Neoplasms
/ genetics
Male
Middle Aged
Myoepithelioma
/ genetics
Octamer Transcription Factor-3
/ genetics
Phenotype
RNA-Binding Protein EWS
/ genetics
RNA-Binding Protein FUS
/ genetics
Soft Tissue Neoplasms
/ genetics
Transcription Factors
/ genetics
Viscera
/ pathology
EWSR1
FUS
PBX1
PBX3
POU5F1
myoepithelial tumors
Journal
Genes, chromosomes & cancer
ISSN: 1098-2264
Titre abrégé: Genes Chromosomes Cancer
Pays: United States
ID NLM: 9007329
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
18
01
2020
revised:
21
01
2020
accepted:
22
01
2020
pubmed:
30
1
2020
medline:
9
2
2021
entrez:
30
1
2020
Statut:
ppublish
Résumé
Myoepithelial tumors (MET) represent a clinicopathologically heterogeneous group of tumors, ranging from benign to highly aggressive lesions. Although MET arising in soft tissue, bone, or viscera share morphologic and immunophenotypic overlap with their salivary gland and cutaneous counterparts, there is still controversy regarding their genetic relationship. Half of MET of soft tissue and bone harbor EWSR1 or FUS related fusions, while MET arising in the salivary gland and skin often show PLAG1 and HMGA2 gene rearrangements. Regardless of the site of origin, the gold standard in diagnosing a MET relies on demonstrating its "myoepithelial immunophenotype" of positivity for EMA/CK and S100 protein or GFAP. However, the morphologic spectrum of MET in soft tissue and bone is quite broad and the above immunoprofile is nonspecific, being shared by other pathogenetically unrelated neoplasms. Moreover, rare MET lack a diagnostic immunoprofile but shows instead the characteristic gene fusions. In this study, we analyzed a large cohort of 66 MET with EWSR1 and FUS gene rearrangements spanning various clinical presentations, to better define their morphologic spectrum and establish relevant pathologic-molecular correlations. Genetic analysis was carried out by FISH for EWSR1/FUS rearrangements and potential partners, and/or by targeted RNA sequencing. Then, 82% showed EWSR1 rearrangement, while 18% had FUS abnormalities. EWSR1-POU5F1 occurred with predilection in malignant MET in children and young adults and these tumors had nested epithelioid morphology and clear cytoplasm. In contrast, EWSR1/FUS-PBX1/3 fusions were associated with benign and sclerotic spindle cell morphology. Tumors with EWSR1-KLF17 showed chordoma-like morphology. Our results demonstrate striking morphologic-molecular correlations in MET of bone, soft tissue and viscera, which might have implications in their clinical behavior.
Identifiants
pubmed: 31994243
doi: 10.1002/gcc.22835
pmc: PMC7170037
mid: NIHMS1578502
doi:
Substances chimiques
EWSR1 protein, human
0
FUS protein, human
0
KLF17 protein, human
0
Octamer Transcription Factor-3
0
POU5F1 protein, human
0
RNA-Binding Protein EWS
0
RNA-Binding Protein FUS
0
Transcription Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
348-356Subventions
Organisme : National Cancer Institute (Cycle for Survival)
ID : P50 CA140146-01
Pays : International
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA217694
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA140146
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Hum Pathol. 2019 Aug;90:45-53
pubmed: 31078563
Virchows Arch. 2012 Jun;460(6):621-8
pubmed: 22569967
Am J Surg Pathol. 2007 Dec;31(12):1813-24
pubmed: 18043035
Am J Surg Pathol. 2003 Sep;27(9):1183-96
pubmed: 12960802
Hum Pathol. 2014 May;45(5):1084-91
pubmed: 24746215
Genes Chromosomes Cancer. 2014 Feb;53(2):183-93
pubmed: 24285434
Adv Anat Pathol. 2000 May;7(3):141-8
pubmed: 10809219
Nat Med. 2014 Dec;20(12):1479-84
pubmed: 25384085
Hum Pathol. 2012 May;43(5):764-8
pubmed: 22154050
Am J Surg Pathol. 2016 Mar;40(3):386-94
pubmed: 26523541
J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):480-490
pubmed: 27721615
Genes Chromosomes Cancer. 2013 Jul;52(7):675-82
pubmed: 23630011
Am J Surg Pathol. 2012 Oct;36(10):1444-51
pubmed: 22982887
Int J Surg Pathol. 2018 Aug;26(5):440-447
pubmed: 29390927
Hum Pathol. 2010 Jul;41(7):927-34
pubmed: 20338616
Genes Chromosomes Cancer. 2019 Sep;58(9):643-649
pubmed: 30920708
Genes Chromosomes Cancer. 2010 Dec;49(12):1114-24
pubmed: 20815032
Am J Surg Pathol. 2011 Nov;35(11):1615-25
pubmed: 21997683
Hum Pathol. 2015 Jan;46(1):26-33
pubmed: 25439740
Adv Anat Pathol. 2014 Nov;21(6):411-9
pubmed: 25299310
Am J Surg Pathol. 2019 Jun;43(6):835-843
pubmed: 30864974
Genes Chromosomes Cancer. 2005 Jun;43(2):217-22
pubmed: 15729702
Surg Pathol Clin. 2017 Sep;10(3):657-674
pubmed: 28797507
Am J Surg Pathol. 2015 Jul;39(7):931-8
pubmed: 25970687
Genes Chromosomes Cancer. 2015 Feb;54(2):63-71
pubmed: 25231231
Virchows Arch. 2018 Jun;472(6):1015-1020
pubmed: 29560513
Am J Surg Pathol. 2008 Apr;32(4):572-80
pubmed: 18301055
Genes Chromosomes Cancer. 2015 May;54(5):267-75
pubmed: 25706482